PDCD1 and glioma: In vivo treatment of exomiR-138 mimic results in downregulation of CTLA-4, PD-1 and Foxp3 on tumor infiltrating CD4+T cells leading to significant decrease of T reg in glioma mouse model (Wei et al., 2016).